Russell Stanley
Echelon Wealth Partners
Russell Stanley, analyst at Echelon Wealth Partners, is a special situations analyst whose primary focuses are industrial products and energy services. Prior to joining Echelon Wealth, he worked with Mackie Research and Jennings Capital Inc. He received his master's degree in business administration (Finance and Strategy) from the Schulich School of Business, York University, and is a CFA charterholder.
Recent Quotes
"We view HLTH's results as demonstrating solid sequential improvement in terms of margins, receivables collection and financial reporting timeliness."
—
Russell Stanley, Research Capital Corporation
(8/4/16)
more >
"HLTH's [Q2/16] results demonstrated sequential revenue and EBITDA improvement from Q1/16 levels, reflecting seasonality in the business."
—
Russell Stanley, Research Capital Corporation
(8/3/16)
more >
"We like HLTH's acquisition of Arizona Vein & Vascular Center, as it expands the company's presence in Arizona and augments the service breadth."
—
Russell Stanley, Research Capital Corporation
(8/2/16)
more >
"We view Mr. Ken Efird's appointment positively, as it represents a promotion-from-within HLTH for a very capable executive."
—
Russell Stanley, Research Capital Corporation
(7/11/16)
more >
"HLTH is an undervalued play on growing demand for high acuity surgery in the U.S."
—
Russell Stanley, Research Capital Corporation
(5/25/16)
more >
"HLTH is an undervalued play on growing demand for high acuity surgery; it's a Buy."
—
Russell Stanley, Research Capital Corporation
(5/3/16)
more >
"HLTH is an undervalued, overlooked play on growing demand for high acuity surgical procedures."
—
Russell Stanley, Research Capital Corporation
(3/28/16)
more >
"HLTH's change to now consider 'distressed asset' deals is positive."
—
Russell Stanley, Research Capital Corporation
(3/17/16)
more >
